Adapting to What’s Next — What You Should Know About COVID-19 Antibody Tests

Charles Darwin with a mask
Photo by CDC on Unsplash

The lack of reagents and substrates has severely limited our ability to test for COVID-19 active infection and now the same scenario is happening with antibody testing.

We may need some 260 million tests just to get started, assuming we need to test our 180 million workers and 80 million students.

--

--

--

Vitreoretinal Surgeon, American Board of Ophthalmology Examination Developer, Patent Holder, Researcher, Entrepreneur

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Empowered Relief: Meeting the Needs of a Nation in Pain

READ/DOWNLOAD! Sapira’s Art and Science of Bedside Diagnosis FULL BOOK PDF & FULL AUDIOBOOK

The Endometrial Function Test and Everything You Need to Know from Implantation Onwards with guest…

The Beyoncé Treatment

Vaccine Development

You’ve Probably Never Heard About Neglected Tropical Diseases

Digital Transformation of Healthcare: IoMT Connectivity, AI, and Value Streams

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Susan M Malinowski, MD

Susan M Malinowski, MD

Vitreoretinal Surgeon, American Board of Ophthalmology Examination Developer, Patent Holder, Researcher, Entrepreneur

More from Medium

Increasing the Reach of Our Embeds

Cross-Pollination: Enabling You To Live More.

CS373 Spring 2022: Nisha Ramesh: Final Entry

The How, When, and Why of Home Butchery